CXCR4 mediated recognition of HIV envelope spike and inhibition by CXCL12.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41027939.
- Also identified by DOI 10.1038/s41467-025-63815-2 and PMC identifier 12485088.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
CCR5 and CXCR4 both act as HIV co-receptors, though CXCR4 is less explored. CXCR4 binds the chemokine CXCL12 to regulate cellular processes and mediate HIV entry, a process that CXCL12 inhibits. Using cryo-EM, we investigate HIV-2 envelope (Env) spike recognition by CXCR4 and how CXCL12 inhibit this interaction. We discover that CXCR4 unexpected forms a tetramer, both alone and in complex. It binds CXCL12 with 4:8 and 8:8 stoichiometries, with the CXCL12 N-terminus inserting into the CXCR4 pocket. Structures of CXCR4-gp120<sup>HIV-2</sup> complex show one or two gp120 molecules per CXCR4 tetramer, with the V3 loop occupying the major sub-pocket of CXCR4 through deep embedment of its GFKF motif. The CXCL12 N-terminus chashes with gp120<sup>HIV-2</sup> V3 loops, explain its inhibitory effect. Docking analyses of other HIV antagonists further clarify their mechanisms. The CXCR4-gp120<sup>HIV-1</sup> model illustrate how V3 loop residues define co-receptor specificity, offering insights into co-receptor switching and therapeutic design.
Medical subject headings
- Receptors, CXCR4
- Chemokine CXCL12
- HIV Envelope Protein gp120
- HIV-2